Mythic Therapeutics

WALTHAM, MA · Founded 2018 · CIK 0001819730 · Biotech · Defunct

HALO antibody-drug conjugate (ADC) platform with tumor microenvironment-activated payloads for solid tumors

mythictx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$53M
3 Form D · Dec 2024
21 months since last filing
Contracts
—
No federal contracts on record
Patents
40
4 granted · 36 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 2 same dayForm D · SEC$18,849,989
Private capital raised· 2 of 2 same dayForm D · SEC$4,749,262
Private capital raisedForm D · SEC$29,868,794
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2335TERAIMMUNE, INC.—$3.0M
2336Decibel Therapeutics—$63M
23373P BIOTECHNOLOGIES, INC.——
2338Mythic Therapeutics—$53M
2339DEEPSEQAI LLC——
2340Tallac Therapeutics, Inc.—$21M
2341AION Healthspan, Inc.—$2.9M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • George EliadesDirector · Executive Officer
  • Brian FiskeDirector · Executive Officer · Promoter
  • Jason HansonDirector
  • Peter HechtDirector
  • Josh KopelmanDirector
  • Alex NicholsDirector · Executive Officer · Promoter
  • Sandra PooleExecutive Officer
  • Bryan RobertsDirector

Patents

USPTO · 4 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.